Mukut Sharma, MD
Orthopaedic Surgery · Hazard, KYNPI 1942329438
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $878 of the $1,004 with a category attached, or 87.5%. Skeletal Dynamics Inc accounts for 87.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $936 and has fallen 96.5% since, to $33 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in KY, where the typical reported total is $5,371.
Across 7 payments — averaging $143.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Skeletal Dynamics Inc$878
- Medical Device Business Services, Inc.$47
- Smith+Nephew$23
- Pacira Pharmaceuticals Incorporated$18
- Ipsen Biopharmaceuticals, Inc$15
- Paragon 28, Inc.$12
- plus $12 from 1 others
What the payments were for
- Travel & lodging$87887%
- Food & beverage$12613%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Skeletal Dynamics Inc | 1 | $878 |
| Medical Device Business Services, Inc. | 1 | $47 |
| Smith+Nephew | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Paragon 28, Inc. | 1 | $12 |
| Gilead | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,004 in reported general payments places this provider in the 20th percentile of 322 orthopaedic surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $5,169 |
| Methylprednisolone Acetate | 166 | $1,736 |
| Cephalexin | 65 | $369 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 75 | $350 |
| Doxycycline Hyclate | 33 | $337 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 36 | $268 |
| Tizanidine Hcl | 33 | $161 |
| Meloxicam | 39 | $82 |
| Ibuprofen | 12 | $57 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Hazard
- Arthur MalkaniLouisville$9.6M
- Jonathan YerasimidesLouisville$4.3M
- John LewisLouisville$1.5M
- Akbar NawabLouisville$1M
- Samer HasanCrestview Hills$976K
- Phillip SingerBowling Green$816K
- Brent MorrisLexington$815K
- Joseph GreeneLouisville$581K
- Raymond GreiweFlorence$546K
- Clint HillPaducah$516K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.